These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36285546)

  • 1. Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset.
    Sahrmann JM; Olsen MA; Stwalley D; Yu H; Dubberke ER
    Clin Infect Dis; 2023 Mar; 76(5):809-815. PubMed ID: 36285546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees.
    Yu H; Alfred T; Nguyen JL; Zhou J; Olsen MA
    Clin Infect Dis; 2023 Feb; 76(3):e1476-e1483. PubMed ID: 35686435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
    Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
    Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults.
    Feuerstadt P; Nelson WW; Drozd EM; Dreyfus J; Dahdal DN; Wong AC; Mohammadi I; Teigland C; Amin A
    J Am Med Dir Assoc; 2022 Oct; 23(10):1721-1728.e19. PubMed ID: 35288083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attributable costs and length of stay of hospital-acquired
    Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
    Mollard S; Lurienne L; Heimann SM; Bandinelli PA
    J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
    Zhang D; Prabhu VS; Marcella SW
    Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.
    Rohra S; Poojary A; Patil P; John S; Michael R; Johnson S; Pardeshi P
    Indian J Med Microbiol; 2023; 46():100425. PubMed ID: 37945118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland.
    Robertson C; Pan J; Kavanagh K; Ford I; McCowan C; Bennie M; Marwick C; Leanord A
    J Hosp Infect; 2020 Nov; 106(3):554-561. PubMed ID: 32717202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between epidemiologic case definition categories and adverse clinical outcome in patients with Clostridiodes difficile infection in San Francisco County, California: a five-year retrospective cohort study.
    Siraw BB; Reingold AL; Meyahnwi D
    BMC Infect Dis; 2023 Feb; 23(1):68. PubMed ID: 36737685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?
    Dubberke ER; McMullen KM; Mayfield JL; Reske KA; Georgantopoulos P; Warren DK; Fraser VJ
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):332-7. PubMed ID: 19239377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.
    Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
    Olsen MA; Young-Xu Y; Stwalley D; Kelly CP; Gerding DN; Saeed MJ; Mahé C; Dubberke ER
    BMC Infect Dis; 2016 Apr; 16():177. PubMed ID: 27102582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.
    Dubberke ER; Butler AM; Hota B; Khan YM; Mangino JE; Mayer J; Popovich KJ; Stevenson KB; Yokoe DS; McDonald LC; Jernigan J; Fraser VJ;
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):518-25. PubMed ID: 19419269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of Clostridium difficile infection rates from 2000 to 2006.
    Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess burden associated with Clostridioides difficile infection in haematological patients occurring during hospitalization with induction chemotherapy in the USA.
    Duhalde L; Lurienne L; Wingen-Heimann SM; Guillou L; Buffet R; Bandinelli PA
    J Hosp Infect; 2020 Apr; 104(4):560-566. PubMed ID: 31870888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.
    Dubberke ER; Olsen MA; Stwalley D; Kelly CP; Gerding DN; Young-Xu Y; Mahé C
    PLoS One; 2016; 11(2):e0146822. PubMed ID: 26859403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.